The Valley Desk

NCT06635824 · Interventional trial

Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)

Overall registry status Active not recruiting

Phase 3

Conditions PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov